This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2023 Apr:181:109490.

doi: 10.1016/j.radonc.2023.109490. Epub 2023 Feb 2.

RE: Venkatesulu et al. (Letter to the Editor)

Susannah G Ellsworth¹, Radhe Mohan², Steven H Lin²

Affiliations

Affiliations

¹ University of Pittsburgh Hillman Cancer Center, Pittsburgh, PA, United States.
² University of Texas MD Anderson Cancer Center, Houston, TX, United States.

PMID: 36736591
DOI: 10.1016/j.radonc.2023.109490

RE: Venkatesulu et al. (Letter to the Editor)

Susannah G Ellsworth et al. Radiother Oncol. 2023 Apr.

. 2023 Apr:181:109490.

doi: 10.1016/j.radonc.2023.109490. Epub 2023 Feb 2.

Authors

Susannah G Ellsworth¹, Radhe Mohan², Steven H Lin²

Affiliations

¹ University of Pittsburgh Hillman Cancer Center, Pittsburgh, PA, United States.
² University of Texas MD Anderson Cancer Center, Houston, TX, United States.

PMID: 36736591
DOI: 10.1016/j.radonc.2023.109490

No abstract available

PubMed Disclaimer

Comment in

With regards to Ellsworth et al. on "Lymphocyte sparing normal tissue effects in the clinic LymphoTEC): A systematic review of dose constraint considerations to mitigate radiation-related lymphopenia in the era of immunotherapy".
Venkatesulu B, Giridhar P. Venkatesulu B, et al. Radiother Oncol. 2023 Apr;181:109496. doi: 10.1016/j.radonc.2023.109496. Epub 2023 Feb 2. Radiother Oncol. 2023. PMID: 36736587 No abstract available.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science